[{"id":"099c10c0-ef78-481a-99a8-5823e77b325c","acronym":"","url":"https://clinicaltrials.gov/study/NCT04470024","created_at":"2021-01-29T07:20:56.485Z","updated_at":"2024-07-02T16:35:41.337Z","phase":"Phase 1","brief_title":"Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC","source_id_and_acronym":"NCT04470024","lead_sponsor":"Providence Health \u0026 Services","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Zynyz (retifanlimab-dlwr) • DPV-001 • ragifilimab (INCAGN1876)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 56","initiation":"Initiation: 08/05/2021","start_date":" 08/05/2021","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 07/31/2024","study_completion_date":" 07/31/2024","last_update_posted":"2023-08-01"},{"id":"6a99724b-100b-480c-8172-9cf9e7740140","acronym":"","url":"https://clinicaltrials.gov/study/NCT02234921","created_at":"2021-01-18T10:29:10.951Z","updated_at":"2024-07-02T16:37:06.241Z","phase":"Phase 1","brief_title":"Pilot Study of DRibble Vaccine for Prostate Cancer Patients","source_id_and_acronym":"NCT02234921","lead_sponsor":"UbiVac","biomarkers":" AR","pipe":"","alterations":" ","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Zyclara (imiquimod) • DPV-001 • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 3","initiation":"Initiation: 10/24/2014","start_date":" 10/24/2014","primary_txt":" Primary completion: 08/15/2018","primary_completion_date":" 08/15/2018","study_txt":" Completion: 08/15/2018","study_completion_date":" 08/15/2018","last_update_posted":"2018-10-11"},{"id":"770d0014-7f8f-4127-8f02-76af16ff06ff","acronym":"","url":"https://clinicaltrials.gov/study/NCT03057340","created_at":"2021-01-18T15:03:29.625Z","updated_at":"2024-07-02T16:37:25.559Z","phase":"Phase 1","brief_title":"The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells","source_id_and_acronym":"NCT03057340","lead_sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","biomarkers":" CSF2","pipe":"","alterations":" ","tags":["CSF2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e DPV-001"],"overall_status":"Unknown status","enrollment":" Enrollment 30","initiation":"Initiation: 06/01/2017","start_date":" 06/01/2017","primary_txt":" Primary completion: 12/01/2019","primary_completion_date":" 12/01/2019","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2017-02-20"},{"id":"f8943e62-b462-476b-b9c4-5a1246a22a0a","acronym":"DRibble","url":"https://clinicaltrials.gov/study/NCT00850785","created_at":"2021-01-29T06:59:15.427Z","updated_at":"2024-07-02T16:37:28.862Z","phase":"Phase 1","brief_title":"Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT00850785 - DRibble","lead_sponsor":"Providence Health \u0026 Services","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • DPV-001"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 01/01/2009","start_date":" 01/01/2009","primary_txt":" Primary completion: 05/01/2012","primary_completion_date":" 05/01/2012","study_txt":" Completion: 05/01/2012","study_completion_date":" 05/01/2012","last_update_posted":"2016-09-27"}]